Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Achtyes

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Brain, Behavior, and Immunity|March 31, 2024
Dysregulated placental expression of kynurenine pathway enzymes is associated with inflammation and depression in pregnancyQiong Sha, Martha L Escobar Galvis, Zachary B Madaj, et al.
Journal of Affective Disorders|December 8, 2022
Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depressionAdrienne Lapidos, Daniela Lopez-Vives, Cortney E Sera, et al.
Brain, Behavior, and Immunity|November 8, 2019
Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depressionEric Achtyes, Sarah A Keaton, LeAnn Smart, et al.
Neuropsychiatric Disease and Treatment|March 24, 2023
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 PandemicBatool Haider, Amy K O'Sullivan, Leona Bessonova, et al.
Psychopharmacology Bulletin|August 23, 2021
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a PrimerSagar V Parikh, Daniela Lopez, Jennifer L Vande Voort, et al.
Journal of Affective Disorders|June 20, 2025
Porphyromonas gingivalis capsular K1 serotype IgG seropositivity is associated with moderate-to-severe depressive symptoms during the first trimester of pregnancyTeodor T Postolache, Qiong Sha, Eric Achtyes, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Molecular Psychiatry|October 15, 2024
The genetics of severe depressionClio E Franklin, Eric Achtyes, Murat Altinay, et al.
The Journal of ECT|June 15, 2022
National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive TherapyPeter P Zandi, Michael Morreale, Irving M Reti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2024
Biological Insights from Schizophrenia-associated Loci in Ancestral PopulationsTim B Bigdeli, Chris Chatzinakos, Jaroslav Bendl, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Brain, Behavior, and Immunity|March 31, 2024
Dysregulated placental expression of kynurenine pathway enzymes is associated with inflammation and depression in pregnancyQiong Sha, Martha L Escobar Galvis, Zachary B Madaj, et al.
Journal of Affective Disorders|December 8, 2022
Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depressionAdrienne Lapidos, Daniela Lopez-Vives, Cortney E Sera, et al.
Brain, Behavior, and Immunity|November 8, 2019
Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depressionEric Achtyes, Sarah A Keaton, LeAnn Smart, et al.
Neuropsychiatric Disease and Treatment|March 24, 2023
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 PandemicBatool Haider, Amy K O'Sullivan, Leona Bessonova, et al.
Psychopharmacology Bulletin|August 23, 2021
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a PrimerSagar V Parikh, Daniela Lopez, Jennifer L Vande Voort, et al.
Journal of Affective Disorders|June 20, 2025
Porphyromonas gingivalis capsular K1 serotype IgG seropositivity is associated with moderate-to-severe depressive symptoms during the first trimester of pregnancyTeodor T Postolache, Qiong Sha, Eric Achtyes, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Molecular Psychiatry|October 15, 2024
The genetics of severe depressionClio E Franklin, Eric Achtyes, Murat Altinay, et al.
The Journal of ECT|June 15, 2022
National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive TherapyPeter P Zandi, Michael Morreale, Irving M Reti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2024
Biological Insights from Schizophrenia-associated Loci in Ancestral PopulationsTim B Bigdeli, Chris Chatzinakos, Jaroslav Bendl, et al.
Pageof 3